High-intensity focused ultrasound strode into the limelight three years ago when GE Healthcare started hooking its MR scanners to a focused ultrasound device developed by the Israeli firm InSightec. The hybrid may have uses outside of its FDA-approved application for the noninvasive surgery of symptomatic uterine fibroids -- including the treatment of cancer. Many companies, such as Philips, and lesser known ones, too, are exploring the potential of HIFU.
High-intensity focused ultrasound strode into the limelight three years ago when GE Healthcare started hooking its MR scanners to a focused ultrasound device developed by the Israeli firm InSightec. The hybrid may have uses outside of its FDA-approved application for the noninvasive surgery of symptomatic uterine fibroids - including the treatment of cancer. Many companies, such as Philips, and lesser known ones, too, are exploring the potential of HIFU.
Using ultrasound to heat or ablate abnormal tissue under imaging guidance paves the way for a very specific and exact kind of noninvasive therapy. But researchers at Duke University's Pratt School of Engineering believe the beneficial effects of HIFU might be amplified, if ultrasound is used not only to heat cancer cells but to shake them.
Preclinical tests at Duke indicate that intense shaking by focused ultrasonic waves ruptures the walls of cancer cells and causes them to leak. This sets off an immune response that attacks and destroys the cancer.
"HIFU in the current form can only be used to treat the primary tumor," said Pei Zhong, an associate professor in Duke's mechanical engineering and materials science department. "We now think that HIFU delivered in a different mode, with emphasis on using mechanical vibration to break apart the tumor cells, may have an even more significant impact in suppressing cancer metastasis by waking up the immune system."
For reasons that are still not completely understood, cancer cells often go largely undetected by the immune system, Zhong said. For an antitumor immune response to be effective, it may need to recognize not only the surface proteins of cancer cells but some of the other proteins locked inside those cells. Zhong calls these proteins "danger signals."
The researchers reported in the Journal of Translational Medicine on Aug. 3 that in a study of mice with colon cancer, mechanical HIFU delivered to the tumors sparked an immune response twice as strong as did thermal HIFU, presumably by releasing a more diverse range of danger signals.
"Our results show that while mechanical HIFU is not as effective as thermal HIFU in killing tumor cells directly, it has the potential to induce a stronger antitumor immune response," Zhong said. "These preliminary findings open up the possibility that we could use heat from HIFU to treat the primary tumor and HIFU-boosted immunotherapy for combating any residual and metastatic tumor cells."
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.